DIANNA DOUGLASS: Open Payments
NPI 1043679079 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 20 payments from 9 companies in 2025. Trend: 2023 $512 · 2024 $331 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
| Janssen Pharmaceuticals, Inc | 4 | $97 |
| ABBVIE INC. | 4 | $76 |
| Axsome Therapeutics, Inc. | 3 | $74 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: REXULTI, VRAYLAR, Auvelity, INVEGA SUSTENNA, FANAPT, XARELTO, SPRAVATO, COBENFY.
Industry payments across MS — which companies pay providers there.
